Evidence map›Paper›PMID 25943190›Full record

ArticleRespiratory research2015

Decreased expression of the NF-κB family member RelB in lung fibroblasts from Smokers with and without COPD potentiates cigarette smoke-induced COX-2 expression.

Jared A Sheridan, Michela Zago, Parameswaran Nair, Pei Z Li, Jean Bourbeau, Wan C Tan, Qutayba Hamid, David H Eidelman, Andrea L Benedetti, Carolyn J Baglole

Open access · goldAbstract readComparative Study
In one paragraph

Article in Respiratory research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Aryl hydrocarbon receptor deficiency causes the development of chronic obstructive pulmonary disease through the integration of multiple pathogenic mechanisms.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  12. Angiotensin-converting enzyme 2 expression in COPD and IPF fibroblasts: the forgotten cell in COVID-19.American journal of physiology. Lung cellular and molecular physiology · 2021
    Article
  13. Article
  14. Article
  15. The Aryl Hydrocarbon Receptor and the Maintenance of Lung Health.International journal of molecular sciences · 2018
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Jared A SheridanDepartment of Medicine, 1001 Decarie Blvd, Montreal, QC, H4A 3J1, Canada. sheridanja88@gmail.com.
Michela ZagoDepartment of Medicine, 1001 Decarie Blvd, Montreal, QC, H4A 3J1, Canada. michela.zago@mail.mcgill.ca.
Parameswaran NairDepartment of Medicine, McMaster University, Hamilton, ON, Canada. parames@mcmaster.ca.
Pei Z LiRespiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill University, Montreal, QC, Canada. pei.li@mail.mcgill.ca.
Jean BourbeauRespiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill University, Montreal, QC, Canada. jean.bourbeau@mcgill.ca.
Wan C TanThe UBC James Hogg Research Centre, University of British Columbia, Vancouver, BC, Canada. wan.tan@hli.ubc.ca.
Qutayba HamidDepartment of Medicine, 1001 Decarie Blvd, Montreal, QC, H4A 3J1, Canada. qutayba.hamid@mcgill.ca.
David H EidelmanDepartment of Medicine, 1001 Decarie Blvd, Montreal, QC, H4A 3J1, Canada. david.h.eidelman@mcgill.ca.
Andrea L BenedettiDepartment of Epidemiology and Biostatistics, 1001 Decarie Blvd, Montreal, QC, H4A 3J1, Canada. andrea.benedetti@mcgill.ca.
Carolyn J BagloleDepartment of Medicine, 1001 Decarie Blvd, Montreal, QC, H4A 3J1, Canada. carolyn.baglole@mcgill.ca.
McGill University Health Centre · CAMcGill University · CAMcMaster University · CASheridan College · CAUniversity of British Columbia Hospital · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

backgroundHeightened inflammation, including expression of COX-2, is associated with COPD pathogenesis. RelB is an NF-κB family member that attenuates COX-2 in response to cigarette smoke by a mechanism that may involve the miRNA miR-146a. There is no information on the expression of RelB in COPD or if RelB prevents COX-2 expression through miR-146a.

methodsRelB, Cox-2 and miR-146a levels were evaluated in lung fibroblasts and blood samples derived from non-smokers (Normal) and smokers (At Risk) with and without COPD by qRT-PCR. RelB and COX-2 protein levels were evaluated by western blot. Human lung fibroblasts from Normal subjects and smokers with and without COPD, along with RelB knock-down (siRNA) in Normal cells, were exposed to cigarette smoke extract (CSE) in vitro and COX-2 mRNA/protein and miR-146a levels assessed.

resultsBasal expression of RelB mRNA and protein were significantly lower in lung cells derived from smokers with and without COPD, the latter of which expressed more Cox-2 mRNA and protein in response to CSE. Knock-down of RelB in Normal fibroblasts increased Cox-2 mRNA and protein induction by CSE. Basal miR-146a levels were not different between the three groups, and only Normal fibroblasts increased miR-146a expression in response to smoke. There was a positive correlation between systemic RelB and Cox-2 mRNA levels and circulating miR-146a levels were higher only in GOLD stage I subjects.

conclusionsOur data indicate that RelB attenuates COX-2 expression in lung structural cells, such that loss of pulmonary RelB may be an important determinant in the aberrant, heightened inflammation associated with COPD pathogenesis.

Indexed as

AgedCells, CulturedCross-Sectional StudiesCyclooxygenase 2FemaleFibroblastsGene Expression RegulationHumansLungMaleMiddle AgedNF-kappa BNicotianaPulmonary Disease, Chronic ObstructiveSmokeSmokingCyclooxygenase 2NF-kappa BPTGS2 protein, humanRELB protein, humanSmokeTranscription Factor RelB

Identifiers

PMID25943190
PMCPMC4427974
OpenAlexW2131477746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.